| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 161 | COMPOSITION FOR USE IN STIMULATING THE INTESTINAL FLORA IN INFANTS DELIVERED BY CAESAREAN SECTION | EP17205437.1 | 2006-10-20 | EP3326634A3 | 2018-07-18 | Boehm, Günther; Knol, Jan; Stahl, Bernd |
The present invention relates to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two, preferably three, different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. |
||||||
| 162 | GLYCERIN-BASED GUMMY CANDY AND FOAM CANDY PRODUCTS WITH PROBIOTIC BACTERIA | EP16727527.0 | 2016-06-08 | EP3302090A1 | 2018-04-11 | DOLMER, Mogens; WINNING, Mette |
| The present invention relates to a glycerin-based candy product comprising probiotic bacteria, said product having a moisture content less than 9% and a water activity (aw) less than 0.5 and comprising a) glycerin in an amount of 10% to 40% (w/w), b) 40% to 75% (w/w) of at least one saccharide or at least one polyol which is not glycerin, or a mixture thereof, c) at least one hydrocolloid, and d) at least one species of a probiotic bacterium. Further, the invention relates to methods for producing a glycerin-based candy product comprising probiotic bacteria. | ||||||
| 163 | STRAIN OF BIFIDOBACTERIUM ANIMALIS SSP. ANIMALIS | EP13824023.9 | 2013-12-10 | EP2934557B1 | 2017-01-04 | LEGRAIN-RASPAUD, Sophie; GROMPONE, Gianfranco; CAPRONNIER, Sandrine; SMOKVINA, Tamara; DEGIVRY, Marie-Christine; LESIC, Biliana; NEUNLIST, Michel |
| 164 | UTILISATIONS DE COMPOSITIONS COMPRENANT DU BIFIDOBACTERIUM ANIMALIS SSP. LACTIS LMG P-28149 | EP15705283.8 | 2015-02-13 | EP3104868A2 | 2016-12-21 | QUINTENS, Johan; LIENART VAN LIDTH DE JEUDE, Jehan; GRANGETTE, Corinne; POT, Bruno; MAKKI, Kassem; WOLOWCZUK, Isabelle; ALARD, Jeanne; LEHRTER-VALENTI, Véronique |
| A composition made from at least one probiotic for the use of same in the curative treatment of body weight gain in an overweight human and/or in the preventive treatment of body weight gain in a human who is overweight or has been overweight, said probiotic being Bifidobacterium animalis ssp. Iactis n° LMG P-28149. | ||||||
| 165 | PET FOOD COMPOSITION HAVING PROBIOTIC BIFIDOBACTERIUM ANIMALIS | EP14872178.0 | 2014-12-22 | EP3082450A1 | 2016-10-26 | MARTINEZ-SERNA VILLAGRAN, Maria Delores; BUND, Rajesh K.; IGWEKALA-NWEKE, Isoken Omosefe |
| A method of producing coated kibble is provided which comprises a kibble; a coating on the kibble comprising a fat; a coating on the kibble comprising a probiotic; wherein the kibble comprises internal glycerin. | ||||||
| 166 | USE OF BIFIDOBACTERIUM ANIMALIS FOR TREATING OR PREVENTING BODY WEIGHT GAIN AND INSULIN RESISTANCE | EP12890225 | 2012-12-20 | EP2935560A4 | 2016-08-31 | SHEN JIAN; WANG JINGJING; ZHAO LIPING; OBIN MARTIN SAUL; DERRIEN MURIEL; ROCHER EMILIE; VAN HYLCKAMA VLIEG JOHAN |
| Provided is the use of Bifidobacterium animalis subsp. lactis strain CNCM I-2494 for decreasing diet-induced body weight gain and improving diet-induced insulin resistance in a subject. | ||||||
| 167 | NOVEL STRAIN OF BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 AND USE THEREOF FOR THE TREATMENT AND/OR PREVENTION OF EXCESS WEIGHT AND OBESITY AND ASSOCIATED DISEASES | EP14755102.2 | 2014-07-17 | EP3048165A1 | 2016-07-27 | MARTORELL GUEROLA, Patricia; CHENOLL CUADROS, Mª Empar; RAMÓN VIDAL, Daniel; ORTIZ SERRANO, Pepa; LLOPIS PLA, Silvia; GONZALEZ MARTÍNEZ, Núria; GENOVÉS MARTÍNEZ, Salvador; CASINOS RAMO, Beatriz; SILVA ANGULO, Ángela; ALEIXANDRE, Amaya |
The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species Bifidobacterium animalis subsp. lactis CECT 8145, the cell components, metabolites and secreted molecules thereof, which, incorporated into food and/or pharmaceutical formulations, can be used in the treatment and/or prevention of excess weight and obesity and related diseases such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, infertility, etc. |
||||||
| 168 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH | EP15181073.6 | 2006-10-06 | EP2984943A1 | 2016-02-17 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides. |
||||||
| 169 | METHOD FOR IMPROVING THE SURVIVAL RATE OF PROBIOTIC | EP11748344.6 | 2011-08-16 | EP2605669B1 | 2015-11-04 | HENRIKSSON, Anders |
| 170 | STRAIN OF BIFIDOBACTERIUM ANIMALIS SSP. ANIMALIS | EP13824023.9 | 2013-12-10 | EP2934557A1 | 2015-10-28 | LEGRAIN-RASPAUD, Sophie; GROMPONE, Gianfranco; CAPRONNIER, Sandrine; SMOKVINA, Tamara; DEGIVRY, Marie-Christine; LESIC, Biliana; NEUNLIST, Michel |
| The invention relates to a novel strain of Bifidobacterium animalis ssp. animalis, which is able, inter alia, to improve the function of the enteric nervous system, and to compositions comprising said novel strain. | ||||||
| 171 | Bifidobacteria for Treating myocardial infarction | EP14179491.7 | 2010-06-18 | EP2808024A1 | 2014-12-03 | Burcelin, Rémy; Carcano, Didier; Lahtinen, Sampo |
This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabets), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions. |
||||||
| 172 | Method for stimulating the intestinal flora in infants delivered by caesarean section | EP09011197.2 | 2006-10-20 | EP2140771B1 | 2013-12-11 | Boehm, Günther; Stahl, Bernd; Knol, Jan |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 173 | BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS | EP10730548.4 | 2010-06-18 | EP2442814A2 | 2012-04-25 | BURCELIN, Rémy; CARCANO, Didier; LAHTINEN, Sampo |
| This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabets), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions. | ||||||
| 174 | Method for stimulating intestinal barrier integrity after non-natural birth | EP11178047.4 | 2006-10-06 | EP2407036A1 | 2012-01-18 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides |
||||||
| 175 | METHOD FOR DECREASING ABDOMINAL GIRTH BY ADMINISTERING A BIFIDOBACTERIUM BACTERIA | EP08863726.9 | 2008-12-19 | EP2224935A2 | 2010-09-08 | GOUPIL-FEUILLERAT, Nathalie; GUYONNET, Denis; JAKOB, Stefan |
| The present invention relates to a method for decreasing abdominal girth in a subject by administering a probiotic, preferably a bacteria of the Bifidobacterium genus, said method being on one aspect of the invention a non therapeutic method, and according to another aspect of the invention being a method for treating IBS. | ||||||
| 176 | COMPOSITION WITH SYNBIOTICS | EP08851912.9 | 2008-11-20 | EP2217095A2 | 2010-08-18 | KNOL, Jan; STAHL, Bernd |
| Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed. | ||||||
| 177 | A PROBIOTIC COMPOSITION | EP08803798.1 | 2008-09-05 | EP2211640A2 | 2010-08-04 | VIEBKE, Christer; FLYNN, Callaghan |
| A probiotic composition comprising a probiotic culture having a probiotic count of between 106 and 1010 cfu/ml or cfu/g gum arabic and a carrier medium is disclosed. The invention also relates to a process for preparing the probiotic composition and to probiotic beverage and food products comprising the probiotic composition. | ||||||
| 178 | Method for stimulating intestinal barrier integrity after birth by caesarean section | EP09161674.8 | 2006-10-06 | EP2105055A1 | 2009-09-30 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides |
||||||
| 179 | Method for decreasing abdominal girth by administering a bifidobacterium bacteria | EP07301736.0 | 2007-12-21 | EP2072053A1 | 2009-06-24 | Goupil-Feuillerat, Nathalie; Guyonnet, Denis; Jakob, Stefan |
The present invention relates to a method for decreasing abdominal girth in a subject by administering a probiotic, preferably a bacteria of the Bifidobacterium genus, said method being on one aspect of the invention a non therapeutic method, and according to another aspect of the invention being a method for treating IBS. |
||||||
| 180 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH | EP06799538.1 | 2006-10-06 | EP1940247B1 | 2009-06-03 | SCHMITT, Joachim; BOEHM, Gunther; BEERMANN, Christopher |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
